Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Adult ADHD

Attention deficit hyperactivity disorder and co(morbidities).

    • Education
    • Neurology
    • RX
  • 3 minute read

Especially in adult attention-deficit/hyperactivity disorder, the issue of comorbidity/differential diagnosis plays a role that should not be underestimated. Experts assume that a large proportion of those affected also have other concomitant diseases. Not infrequently, however, only these are diagnosed and ADHD remains hidden behind the mask of comorbidity.

Symptoms of adult attention-deficit/hyperactivity disorder (ADHD) may be hidden behind comorbid medical conditions. In fact, in many cases, newly diagnosed patients first stand out because of other psychiatric illnesses. However, that comorbidities are the rule rather than the exception in adult ADHD patients was shown by a multicenter observational study in adults: At the time of ADHD diagnosis, psychiatric morbidity was 66.2%, with more males affected. The most common comorbidities of adult ADHD include addictive disorders (39%), anxiety disorders (23%), and affective disorders such as depression, mania, or bipolar (18%). The “big four” ADHD comorbidities include personality disorders. However, due to the great effort involved in recording these diagnoses, no reliable epidemiological data are available.

Symptom overlap possible

Recognition of the different diseases is complicated by the fact that symptom overlap is not uncommon. Core symptoms of ADHD are problems with attention, overactivity and impulsivity. These are chronically present. In bipolar disorder, for example, they also occur – but exclusively during episodes of illness. ADHD is classified as a developmental disorder and starts in childhood. Bipolar disorder, on the other hand, usually begins in late adolescence or adulthood. Similar to a manic episode, ADHD patients have increased drive, increased verbal fluency, increased impulsivity, and a tendency to engage in dangerous activities. In addition, ADHD patients are easily distracted, erratic in their formal thought process, and start many activities at once without finishing them.

A similar situation applies to depression. Both ADHD and a depressive episode have some of the same or similar symptoms – especially psychomotor agitation and difficulty concentrating. However, in extreme cases, depressive symptomatology can mask ADHD for years and prevent targeted therapy. As a rule, adults suffering from ADHD often seek psychiatric help “only” because of depression. Therefore, at the latest when the patient turns out to be resistant to therapy, one should also think in the direction of ADHD.

Which disease to treat first?

The decision about ADHD pharmacotherapy is based on the nature and severity of each comorbid condition. In principle, treatment with stimulants is indicated when ADHD is the primary condition. The drug of choice for this is methylphenidate. Pharmacotherapy in adult ADHD patients is now recommended not only for severe, but also for mild or moderate expression, provided this is consistent with the patient’s preferences. Often, reduction of ADHD symptom severity also improves symptoms of a comorbid condition. In the case of a comorbid depressive disorder, there is usually nothing to prevent concurrent drug treatment. However, in case of mania, it should be treated first. This is the prerequisite for making therapy of ADHD symptoms possible in the first place. Alcohol abuse and cannabis use are generally not strict contraindications for drug therapy. However, it is necessary to work toward abstinence during the course of treatment. In the case of abuse of cocaine, amphetamines or opiates or polytoxicomania, on the other hand, the focus is on detoxification.

 

Further reading:

  • Pineiro-Dieguez B, et al: Psychiatric Comorbidity at the Time of Diagnosis in Adults with ADHD: The CAT Study. J Atten Disord 2016; 20: 1066-1075.
  • Torgersen T, et al: ADHD in adults: a study of clinical characteristics, impairment and comorbidity. Nord J Psychiatry 2006; 60(1): 38-43.
  • Rostain AL: Attention-deficit/hyperactivity disorder in adults: evidence-based recommendations for management. Postgrad Med 2008, 120(3): 27-38.
  • S3 guideline “ADHD in children, adolescents and adults”; as of 02.05.2017; www.awmf.org/leitlinien/detail/ll/028-045.html
Autoren
  • Leoni Burggraf
Publikation
  • InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
  • ADHD
  • adult ADHD
  • Comorbidity
Previous Article
  • Ten years of living with Fukushima

The nuclear disaster and cancer

  • Congress Reports
  • Endocrinology and Diabetology
  • Oncology
  • RX
View Post
Next Article
  • Vesicoureteral reflux (VUR)

Proven minimally invasive therapy option for children

  • General Internal Medicine
  • Market & Medicine
  • Pediatrics
  • RX
  • Urology
View Post
You May Also Like
View Post
  • 4 min
  • HER2+ early breast cancer

DESTINY-Breast11 – neoadjuvant T-DXd without anthracyclines

    • Education
    • Gynecology
    • Oncology
    • RX
    • Studies
View Post
  • 3 min
  • Lavender aromatherapy

Take away the fear of the dentist

    • Dentistry
    • Education
    • Pharmaceutical medicine
    • Phytotherapy
    • Psychiatry and psychotherapy
    • RX
    • Studies
View Post
  • 4 min
  • Digital dermatology: innovative project examples

AI and eHealth tools in HS care

    • Dermatology and venereology
    • General Internal Medicine
    • Practice Management
    • Prevention and health care
    • RX
    • Studies
View Post
  • 5 min
  • Mantle cell lymphoma

Recurrence after BTK inhibition – prognostic factors and treatment options

    • Education
    • Hematology
    • Oncology
    • RX
View Post
  • 3 min
  • Dementia risk with type 2 diabetes

SGLT2 inhibitors with advantages vs. DPP4 inhibitors

    • Education
    • Endocrinology and Diabetology
    • Geriatrics
    • Neurology
    • Pharmacology and toxicology
    • Psychiatry and psychotherapy
    • RX
    • Studies
View Post
  • 15 min
  • T helper 1 cells

Differentiation and activation of Th1 cells – a multi-omics approach

    • RX
    • CME continuing education
    • General Internal Medicine
    • Genetics
    • Prevention and health care
View Post
  • 4 min
  • Cannabis for schizophrenia

CBD pre-treatment could exacerbate side effects

    • Education
    • Pharmacology and toxicology
    • Phytotherapy
    • Psychiatry and psychotherapy
    • RX
    • Studies
View Post
  • 11 min
  • Type 2 diabetes: cardiovascular risk reduction is realistic

Modern active ingredients and lifestyle – every step counts

    • Cardiology
    • Congress Reports
    • Endocrinology and Diabetology
    • Prevention and health care
    • RX
    • Studies
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Communication as the key to therapy adherence
  • 2
    Solutions to the malnutrition dilemma
  • 3
    Solutions to the malnutrition dilemma
  • 4
    Focus on preventive care options
  • 5
    Fertility preservation from gonads to genomes to genoids

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.